Drug Price Transparency in Medicaid Act of 2023

Summary

Drug Price Transparency in Medicaid Act of 2023 This bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid. The bill also extends funding for retail pharmacy surveys and requires additional information with respect to price concessions and survey participation to be made publicly available.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 29 March 2023

   Introduced

   Read twice and referred to the Committee on Finance.

   Source: IntroReferral

2. 29 March 2023

   Introduced

   Introduced in Senate

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

• Introduced in Senate · 29 March 2023 · Official file

Documents

3 official files

• Introduced in Senate (text)

  Introduced in Senate · EN · 29 March 2023

  ViewDownloadOpen at official source

• Introduced in Senate (PDF)

  Introduced in Senate · EN · 29 March 2023

  ViewDownloadOpen at official source

• Introduced in Senate

  summary · EN · 29 March 2023

  Open at official source

Sponsors

• Peter Welch · D · Sponsor
• Roger Marshall · R · Sponsor
• Shelley Capito · R · Cosponsor
• Kirsten Gillibrand · D · Cosponsor
• · ssfi00 · Standing

Related records

• related to → Drug Price Transparency in Medicaid Act of 2023
• related to ← PATIENT Act of 2023